Summary
Nodular palmar fibromatosis is a self-limited proliferation of fibro-/myofibroblasts associated with growth factor synthesis and abundant fibronectin extracellular matrix deposition. bFGF and TGFβ are potent modulators of fibro-/myofibroblast proliferation and differentiation. Moreover,in vitro investigations evidenced a TGFβ1-dependent regulation of alternative splicing of fibronectin mRNA. To investigate a possible implication of these growth factors in the tissue formation process of palmar fibromatosis, TGFβ1/2 and bFGF synthesis, as well as TGFβ1/3 and bFGF tissue distribution, is demonstrated by RNAin situ hybridization and/or immunohistochemistry in relation to myofibroblast phenotype development (α-smooth muscle actin, desmin immunohistochemistry), expression of different fibronectin isoforms (ED-A+, ED-B+ and oncofetal glycosylated fibronectin immunohistochemistry, fibronectin RNAin situ hybridization) and cellular activity (cyclin RNAin situ hybridization, Ki-67 immunolabelling). The myofibroblast phenotype (α-smooth muscle actin, desmin), the growth factor synthesis (TGFβ1 and 2, bFGF), fibronectin matrix synthesis (RNAin situ hybridization with cDNA) and ED-A+, ED-B+ and oncofetal glycosylated fibronectin immunostaining are exclusively localized in the active proliferative nodules (Ki-67 immunolabelling and cyclin mRNA demonstration). Whereas the growth factor synthesis is restricted to the proliferative areas of the fibromatosis only, TGFβ1, TGFβ3 and bFGF proteins can also be detected immunohistochemically with a lower intensity in the surrounding aponeurotic tissue. The spatial correlation of myofibroblast phenotype, TGFβ and bFGF synthesis and the occurrence of the oncofetal molecular fibronectin variants (ED-B+ and oncofetal glycosylated fibronectin) in the active proliferative fibromatosis nodules suggests a pathogentic role of these growth factors and matrix components in the tumorous tissue formation process. The presence of the bFGF and TGFβ1/3 proteins in fibroblasts neighbouring the proliferative nodules may point to a recruitment of quiescent aponeurotic fibroblasts in the fibromatous tissue formation process.
Similar content being viewed by others
References
Adams,J. C. &Watt,F. M. (1993) Regulation of development and differentiation by the extracellular matrix.Development 117, 1183–98.
Bachem,M. G.,Sell,K. -M.,Melchior,R.,Kropf,J.,Eller,T. &Gressner,A. M. (1993) Tumor necrosis factor alpha (TNFα) and transforming growth factor β1 (TGFβ1) stimulate fibronectin synthesis and the transdifferentiation of fat-storing cells in the rat liver into myofibroblasts.Virchows Archiv. B Cell Pathol. 63, 123–30.
Baird,A. &Walicke,P. (1989) Fibroblast growth factors.Br. Med. Bull. 45, 438–52.
Baird,K. S.,Crossan,J. F. &Ralston,S. H. (1993) Abnormal growth factor and cytokine expression in Dupuytren's contracture.J. Clin. Pathol. 46, 425–8.
Balza,E.,Borsi,L.,Allemanni,G. &Zardi,L. (1988) Transforming growth factor β regulates the level of different fibronectin isoforms in normal human cultured fibroblasts.FEBS Lett. 228, 42–4.
Berndt,A.,Kosmehl,H. &Katenkapmp,D. (1993) Analyse der myofibroblastären Basallamina in der Proliferationsphase der Dupuytrenschen Palmarfibromatose.Verh. Dtsch. Ges. Path. 77, 389.
Berndt,A.,Kosmehl,H.,Katenkamp,D. &Tauchmann,V. (1994) Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.Pathobiology 62, 55–8.
Bissell,M. J.,Hall,H. G. &Parry,G. (1982) How does the extracellular matrix direct gene expression?J. Theor. Biol. 99, 31–68.
Björkerud,S. (1991) Effects of transforming growth factor-β1 on human arterial smooth muscle cellsin vitro.Arterioscler. Thromb. 11, 892–902.
Borsi,L.,Carnemolla,B.,Castellani,P.,Rossellini,C.,Vecchio,D.,Allemanni,G.,Chang,S. E.,Taylor-Papadimitriou,J.,Pande,H. &Zardi,L. (1987) Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells cells.J. Cell. Biol. 104, 595–600.
Borsi,L.,Castellani,P.,Risso,A. M.,Leprini,A. &Zardi,L. (1990) Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor.FEBS Lett. 261, 175–8.
Burgess,W. H. &Maciag,T. (1989) The heparin-binding (fibroblast) growth factor family of proteins.Annu. Rev. Biochem. 58, 575–606.
Carnemolla,B.,Balza,E.,Siri,A.,Zardi,L.,Nicotra,M. R.,Bigotti,A. &Natali,P. G. (1989) A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precusors.J. Cell Biol. 108, 1139–48.
Carnemolla,B.,Leprini,A.,Allemanni,G.,Saginati,M. &Zardi,L. (1992) The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence.J. Biol Chem. 267, 24689–92.
David,L.,Mandel,U.,Clausen,H. &Sobrinhosimoes,M. (1993) Immunhistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach.Eur. J. Cancer 29A, 2070–1.
Desmouliere,A.,Geinoz,A.,Gabbiani,F. &Gavviani,G. (1993) Transforming growth factor-β1 induces α-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.J. Cell Biol. 122, 103–11.
Eddy,R. J.,Petro,J. A. &Tomasek,J. J. (1988) Evidence for the nonmuscle nature of the ‘myofibroblast’ of granulation tissue and hypertropic scar. An immunofluorescence study.Am. J. Pathol. 130, 252–60.
Enenstein,J.,Waleh,N. S. &Kramer,R. H. (1992) Basic FGF and TGF-β differentially modulate integrin expression of human microvascular endothelial cells.Exp. Cell Res. 203, 499–503.
Ffrench-Constant,C.,van deWater,L.,Dvorak,H. F. &Hynes,R. O. (1989) Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat.J. Cell Biol. 109, 903–14.
Gonzalez,A. -M.,Buscaglia,M.,Fox,R.,Isacchi,A.,Sarmientos,P.,Farris,J.,Ong,M.,Martineau,D.,Lappi,D. A. &Baird,A. (1992) Basic fibroblast growth factor in Dupuytren's contracture.Am. J. Pathol. 141, 661–71.
Grande,J.,Melder,D.,Zinsmeister,A. &Killen,P. (1993) Transforming growth factor-β1 induces collagen IV gene expression in NIH-3T3 cells.Lab. Invest. 69, 387–95.
Gustmann,C.,Altmannsberger,M.,Osborn,M.,Griesser,H. &Feller,A. C. (1991) Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphoma.Am. J. Pathol. 138, 1413–22.
Halliday,N. L.,Rayan,G. M.,Zardi,L. &TomasekJ. J. (1994) Distribution of ED-A and ED-B containing fibronectin isoforms in Dupuytren's disease.J. Hand. Surg. 19A, 428–34.
Herlyn,M. &Malkowicz,S. B. (1991) Biology of disease. Regulatory pathways in tumor growth and invasion.Lab. Invest. 65 262–71.
Kornblihtt,A. R.,Vibe-Pedersen,K. &Baraville,F. E. (1983) Isolation and characterization of cDNA clones for human and bovine fibronectins.Proc. Natl Acad. Sci. USA 80, 3218–22.
Kornblihtt,A. R.,Umezawa,K.,Vibe-Pedersen,K. &Baralle,F. E. (1985) Primary structure of human fibronectin: Differential splicing may generate at least 10 polypeptides from a single gene.EMBO J. 4, 1755–9.
Kosmehl, H. Berndt, A., Katenkamp, D., Mandel, U., Bohle, R., Gabler, U. &Celeda, D. (1995) Differential expression of fibronectin splice variants, oncofetal glycosylated fibronectin and laminin isoforms in nodular palmar fibromatosis.Path. Res. Pract.,191, in press.
Luck,J. V. (1959) Dupuytren's contracture. A new concept of the pathogenesis correlated with surgical development.J. Bone Joint Surg. 41-A, 635–64.
Mandel,U.,Therkildsen,M. H.,Reibl,J.,Sweeney,B.,Matsuura,H.,Hakomori,S. -I.,Dabelsteen,E. &Clausen,H. (1992) Cancer-associated changes in glycosylation of fibronectin.APMIS 100, 817–26.
Okragly,A.,Balwit,J. M. &Haak-Frendscho,M. (1994) Transforming growth factor β 1 (TGFβ1): A biological paradox.Promega Notes 47, 10–14.
Perosio,P. M. &Brooks,J. J. (1989) Expression of growth factors and growth factor receptors in soft tissue tumors. Implications for the autocrine hypothesis.Lab. Invest. 60, 245–53.
Roholl,P. J. M.,Weima,S. M.,Prinsen,I.,DeWeger,R. A.,DenOtter,W. &VanUnnik,J. A. M. (1991) Expression of growth factors and their receptors on human sarcoma. Immunohistochemical detection of platelet-derived growth factor, epidermal growth factor and their receptors.Cancer J. 4, 83–8.
Rønnov-Jessen,L. &Petersen,O. W. (1993) Induction of α-smooth muscle actin by transforming growth factor-β1 in quiescent human breast gland fibroblasts.Lab Invest. 68, 696–707.
Schürch,W.,SeemayerT. A. &GabbianiG. (1992) Myofibroblast. InHistology for Pathologists (edited bySterngerg,S. S.), pp. 109–44. New York: Raven Press.
Schwarzbauer,J. E. (1991) Alternative splicing of fibronectin: three variants, three functions.BioEssays 13, 527–33.
Singer,I. I. (1979) The fibronexus: A transmembrane association of fibronectin containing fibers and bundles of 5 nm microfilaments in hamster and human fibroblasts.Cell 16, 675–85.
Sporn,M. B. &Roberts,A. B. (1988) Peptide growth factors are multifunctional.Nature 332, 217–19.
Sporn,M. B.,Roberts,A. B.,Wakefield,L. M. &DeCrombrugghe,B. (1987) Some recent advances in the chemistry and biology of transforming growth factor-beta.J. Cell Biol. 105, 1039–331.
Tan,E. M. L.,Hoffren,J.,Rouda,S.,Greenbaum,S.,Fox,J. W.Moore,J. H. &Dodge,G. R. (1993) Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor.Exp. Cell Res. 209, 200–7.
Tomasek,J. J.,Schultz,R. J.,Episalla,C. W. &Newman,S. A. (1986) The cytoskeleton and extracellular matrix of the Dupuytren's disease ‘myofibroblast’: An immunofluorescence study of a nonmuscle cell type.J. Hand Surg. 11A, 365–71.
Wang,A.,Cohen,D. S.,Palmer,E. &Sheppard,D. (1991) Polarized regulation of fibronectin secretion and alternative splicing by transforming growth factor β.J. Biol. Chem. 266, 15598–601.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berndt, A., Kosmehl, H., Mandel, U. et al. TGFβ and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin. Histochem J 27, 1014–1020 (1995). https://doi.org/10.1007/BF02389692
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02389692